Appearance of antidepressant-like effect by sildenafil in rats after central muscarinic receptor blockade: evidence from behavioural and neuro-receptor studies
- 7 September 2007
- journal article
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 115 (1) , 117-125
Abstract
The phosphodiesterase (PDE) 5 inhibitor sildenafil has been shown to display psychotropic actions in humans and animals, and has been used for the treatment of antidepressant-associated erectile dysfunction. However, its effects on the neurobiology of depression are unknown. Nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) inhibition is anti-depressant in animals, and increasing cGMP with sildenafil is anxiogenic in rodents. Substantial cholinergic-nitrergic interaction exists in the brain, while sildenafil shows modulatory actions on cholinergic transmission. Depression is also associated with increased cholinergic drive. Here we report that sildenafil increases muscarinic acetylcholine receptor (mAChR) signaling in human neuroblastoma cells. We also show that fluoxetine (20 mg/kg/day × 7 days), as well as a combination of sildenafil (10 mg/kg/day × 7 days) plus the antimuscarinic atropine (1 mg/kg/day × 7 days) demonstrates significant, comparable antidepressant-like effects in the rat forced swim test (FST) and also reduces cortical β-adrenergic receptor (β-AR) density, while sildenafil or atropine alone did not. Importantly, sildenafil did not modify fluoxetine’s response. Sildenafil thus demonstrates antidepressant-like effects but only after central muscarinic receptor blockade, providing evidence for cholinergic-nitrergic interactions in the neurobiology of depression.Keywords
This publication has 54 references indexed in Scilit:
- Phosphodiesterase genes are associated with susceptibility to major depression and antidepressant treatment responseProceedings of the National Academy of Sciences, 2006
- Antidepressant Efficacy of the Antimuscarinic Drug ScopolamineArchives of General Psychiatry, 2006
- Alteration of Decreased Plasma NO Metabolites and Platelet NO Synthase Activity by Paroxetine in Depressed PatientsNeuropsychopharmacology, 2005
- Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in ratsPharmacology Biochemistry and Behavior, 2005
- Phenoxybenzamine and Benextramine, but Not 4-Diphenylacetoxy-N-[2-chloroethyl]piperidine Hydrochloride, Display Irreversible Noncompetitive Antagonism at G Protein-Coupled ReceptorsThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Involvement of the NMDA receptor, NO‐cyclic GMP and nuclear factor K‐β in an animal model of repeated traumaHuman Psychopharmacology: Clinical and Experimental, 2005
- Glutamate and DepressionAnnals of the New York Academy of Sciences, 2003
- Muscarinic Receptor Sequestration in SH‐SY5Y Neuroblastoma Cells Is Inhibited when Clathrin Distribution Is PerturbedJournal of Neurochemistry, 1996
- The Adrenergic-Cholinergic Imbalance Hypothesis of Depression: A Review and a PerspectiveReviews in the Neurosciences, 1993
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976